Biomarkers, Treatments, and Comorbidities: Translating Data to Clinical Practice When Managing Patients with Multiple Sclerosis
neuroscienceCME WebcastPremiere Date: Sunday, February 5, 2017
This activity offers CE credit for:%>
- Physicians (CME)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Monday, February 5, 2018
Note: Credit Is No Longer Available
|Derrick Robertson, MD
Assistant Professor of Neurology
Director, USF Multiple Sclerosis Division
Program Director, USF Multiple Sclerosis Fellowship
Associate Program Director, USF Neurology Residency
University of South Florida, College of Medicine
This video is a replay of a plenary session from the 9th Annual Chair Summit Master Class for Neuroscience Professional Development held in Miami, Florida on September 15 – 17, 2016.
At the end of this CE activity, participants should be able to:
- Examine the incidence of MS misdiagnosis and develop strategies to improve diagnosis.
- Review the clinical course of MS and its significance to treatment selection.
- Examine the current treatment landscape for MS and recent clinical updates.
This activity is supported by CME Outfitters, LLC.
Physicians, physician assistants, nurse practitioners, and other healthcare professionals with an interest in psychiatry, neurology, and the neurosciences.
CME Credit (Physicians):
CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Robertson has disclosed that he receives grant support from Biogen; Genzyme Corporation; Novartis; Sun Pharma; MedImmune; Actelion Pharmaceuticals US, Inc.; Mallinckrodt Pharmaceuticals; EMD Serono, Inc.; Genentech, Inc. He serves as a consultant for Biogen; Genzyme Corporation; Pfizer Inc.; Teva Neuroscience, Inc. He is on the speakers bureau of Acorda Therapeutics; Biogen; EMD Serono, Inc.; Genzyme Corporation; Mallinckrodt Pharmaceuticals; Pfizer Inc.; Teva Neuroscience, Inc.
Howard Bliwise, MD (peer reviewer) has no disclosures to report.
Robert Kennedy (planning committee) has no disclosures to report.
Sharon Tordoff, CHCP (planning committee) has no disclosures to report.
Jan Perez, CHCP (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).